Results 231 to 240 of about 34,628,233 (409)

Outcome analysis of accreditacion processes for chilean nursing programs [PDF]

open access: diamond, 2010
Verónica Guerra Guerrero   +1 more
openalex   +1 more source

SAFE Homes statistical reports, Q4 SFY 2001

open access: yes, 2001
Quarterly; 4/1/2001 to 6/30/2001-; Title from caption (viewed June 8, 2004).; Latest issue consulted: 01/01/2004 to 03/31/2004.; Issued in multiple vols.; Volumes for 4/1/2001 to 6/30/2001-10/1/2001 to 12/31/2001, 10/1/2003 to 12/31/2003- issued by Dept.
SAFE Homes (Program)
core  

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

SAFE Homes statistical reports, Q1 SFY 2005

open access: yes, 2001
Quarterly; 4/1/2001 to 6/30/2001-; Title from caption (viewed June 8, 2004).; Latest issue consulted: 01/01/2004 to 03/31/2004.; Issued in multiple vols.; Volumes for 4/1/2001 to 6/30/2001-10/1/2001 to 12/31/2001, 10/1/2003 to 12/31/2003- issued by Dept.
SAFE Homes (Program)
core  

What developers want and need from program analysis: An empirical study

open access: yesInternational Conference on Automated Software Engineering, 2016
M. Christakis, C. Bird
semanticscholar   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy